Healthcare provider profile · identity verified

Joellen Heims, DO

Family Practice · CARLISLE, IA · NPI 1609883149

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	427	93
Atorvastatin Calcium	Atorvastatin Calcium	364	101
Omeprazole	Omeprazole	320	88
Simvastatin	Simvastatin	267	66
Lisinopril	Lisinopril	248	63
Escitalopram Oxalate	Escitalopram Oxalate	230	55
Amlodipine Besylate	Amlodipine Besylate	229	59
Metformin Hcl	Metformin Hcl	218	56
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	192	47
Albuterol Sulfate Hfa	Albuterol Sulfate	165	35
Losartan Potassium	Losartan Potassium	164	44
Hydrochlorothiazide	Hydrochlorothiazide	156	45
Alprazolam	Alprazolam	137	20
Pantoprazole Sodium	Pantoprazole Sodium	135	37
Duloxetine Hcl	Duloxetine Hcl	133	30
Gabapentin	Gabapentin	128	37
Furosemide	Furosemide	123	34
Glipizide Er	Glipizide	121	28
Metoprolol Succinate	Metoprolol Succinate	121	29
Lorazepam	Lorazepam	119	22
Meloxicam	Meloxicam	117	34
Tramadol Hcl	Tramadol Hcl	108	31
Trazodone Hcl	Trazodone Hcl	103	23
Pregabalin	Pregabalin	97	15
Celecoxib	Celecoxib	93	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	92	28
Prednisone	Prednisone	90	60
Bupropion Xl	Bupropion Hcl	88	23
Sertraline Hcl	Sertraline Hcl	85	22
Rosuvastatin Calcium	Rosuvastatin Calcium	83	27
Zolpidem Tartrate	Zolpidem Tartrate	79	14
Amitriptyline Hcl	Amitriptyline Hcl	78	16
Metoprolol Tartrate	Metoprolol Tartrate	76	20
Ozempic	Semaglutide	75	12
Aripiprazole	Aripiprazole	73	15
Montelukast Sodium	Montelukast Sodium	73	16
Tamsulosin Hcl	Tamsulosin Hcl	71	19
Baclofen	Baclofen	68	12
Citalopram Hbr	Citalopram Hydrobromide	65	17
Fluticasone Propionate	Fluticasone Propionate	64	23
Pioglitazone Hcl	Pioglitazone Hcl	62	14
Fluoxetine Hcl	Fluoxetine Hcl	59	14
Tizanidine Hcl	Tizanidine Hcl	58	16
Eliquis	Apixaban	56	12
Clonazepam	Clonazepam	55	suppressed
Diclofenac Sodium	Diclofenac Sodium	51	11
Jardiance	Empagliflozin	51	12
Venlafaxine Hcl Er	Venlafaxine Hcl	50	11
Metformin Hcl Er	Metformin Hcl	49	suppressed
Ondansetron Hcl	Ondansetron Hcl	48	suppressed
Pravastatin Sodium	Pravastatin Sodium	48	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	12
Alendronate Sodium	Alendronate Sodium	44	16
Oxycodone Hcl	Oxycodone Hcl	44	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	44	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	43	38
Warfarin Sodium	Warfarin Sodium	43	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	40	11
Allopurinol	Allopurinol	39	11
Naproxen	Naproxen	38	13
Famotidine	Famotidine	36	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	19
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	20
Xarelto	Rivaroxaban	32	suppressed
Spironolactone	Spironolactone	31	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Cephalexin	Cephalexin	29	21
Amiodarone Hcl	Amiodarone Hcl	28	suppressed
Bumetanide	Bumetanide	28	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Azithromycin	Azithromycin	27	23
Benazepril Hcl	Benazepril Hcl	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Potassium Chloride	Potassium Chloride	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Atenolol	Atenolol	25	suppressed
Carvedilol	Carvedilol	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Fluconazole	Fluconazole	25	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Temazepam	Temazepam	23	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	22	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Topiramate	Topiramate	19	suppressed
Finasteride	Finasteride	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Glipizide	Glipizide	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Levofloxacin	Levofloxacin	15	suppressed
Nystatin	Nystatin	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Guanfacine Hcl	Guanfacine Hcl	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Nyamyc	Nystatin	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error